Evidence map›Paper›PMID 27919909›Full record

ArticleBlood2017

Severe anemia early in life as a risk factor for sickle-cell kidney disease.

Inmaculada Aban, Sujatha Baddam, Lee M Hilliard, Thomas H Howard, Daniel I Feig, Jeffrey D Lebensburger

Registry-linked trialOpen access · bronzeAbstract readLetter
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02373241 (Chronobiology and Chronopharmacology to Prevent Sickle Cell Kidney Disease), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02373241 phase2terminatednot on this map

Chronobiology and Chronopharmacology to Prevent Sickle Cell Kidney Disease

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2015 to 2021Enrolled1ConditionsAnemia, Sickle Cell, Sickle Cell Disease, Kidney Disease, HypertensionArmsLosartan
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Sickle Cell Disease and CKD: An Update.American journal of nephrology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Inmaculada AbanDepartment of Biostatistics.
Sujatha BaddamPediatric Hematology and Oncology, and.
Lee M HilliardPediatric Hematology and Oncology, and.
Thomas H HowardPediatric Hematology and Oncology, and.
Daniel I FeigPediatric Nephrology, University of Alabama at Birmingham, Birmingham, AL.
Jeffrey D LebensburgerPediatric Hematology and Oncology, and.ORCID 0000-0001-5011-1022
Palmetto Hematology Oncology · USCancer Research And Biostatistics · USUniversity of Alabama at Birmingham · US

Funding

Chronobiology and Chronopharmacology to Prevent Sickle Cell NephropathyK23HL127100 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEBENSBURGER, JEFFREY D · 2015 to 2019
$916k
NHLBI NIH HHS K23 HL127100
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAnemia, Sickle CellChildFemaleHumansKidney DiseasesMaleRisk Factors

Identifiers

PMID27919909
PMCPMC5248934
OpenAlexW2559974327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.